Pathstone Holdings’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-30,263
Closed -$389K – 2192
2025
Q1
$389K Buy
30,263
+2,772
+10% +$44.6K ﹤0.01% 1832
2024
Q4
$474K Sell
27,491
-11,988
-30% -$240K ﹤0.01% 1740
2024
Q3
$891K Buy
39,479
+5,126
+15% +$117K ﹤0.01% 1434
2024
Q2
$849K Buy
34,353
+13,089
+62% +$372K ﹤0.01% 1414
2024
Q1
$700K Buy
+21,264
New +$724K ﹤0.01% 1513

Other funds holding ADNT

Pathstone Holdings's ADNT Position: Q2 2025 in Review

Pathstone Holdings sold out of Adient (ADNT) in Q2 2025, closing a stake of 30,263 shares — an estimated $389K sold.

Pathstone Holdings first reported a position in ADNT in Q1 2024 and held it in 5 quarters. The position peaked at $891K in Q3 2024. 268 funds tracked by Wall St. Rank hold ADNT as of Q2 2025.

  • Pathstone Holdings reported no remaining Adient position as of Q2 2025 after selling out during the quarter.
  • Pathstone Holdings sold 30,263 Adient shares in Q2 2025, an estimated $389K.
  • Pathstone Holdings first reported a position in Adient in Q1 2024 and held it in 5 quarters.
  • Pathstone Holdings's Adient position peaked at $891K in Q3 2024.
  • 268 funds tracked by Wall St. Rank held Adient as of Q2 2025.

Based on Pathstone Holdings's 13F filing for Q2 2025, filed 12 Aug 2025.